CLINICAL_TRIALS
trial_result
· 2024-12-13
Clinical Trial Update: Clinical Trial of DA-5212 in Patients with Functional Dyspepsia [Phase 3]
Summary
A Phase 3 trial evaluating DA-5212 in functional dyspepsia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dong-A ST Co., Ltd. | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED